Medicare Enrolled

Dr. Roberto Ochoa Planchart, MD

Hematology & Oncology · Hialeah, FL
5961 NW 173RD DR, Hialeah, FL 33015
3055567500
Registered in NPPES since 2008
NPI: 1962659466 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ochoa Planchart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ochoa Planchart? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ochoa Planchart

Dr. Roberto Ochoa Planchart is a hematology & oncology specialist in Hialeah, FL, with 18 years of NPI registration.

Between the years covered by Open Payments, Dr. Ochoa Planchart received a total of $6,349 from 61 pharmaceutical and/or device companies across 255 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ochoa Planchart is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration $6,349 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,349
Total received (2022-2024)
Avg $2,116/year across 3 years
Top 43% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
255
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,764
2023
$2,552
2022
$33

Payments by company (2024)

PFIZER INC.
$284
Daiichi Sankyo Inc.
$268
Tempus AI, Inc
$218
GlaxoSmithKline, LLC.
$193
Merck Sharp & Dohme LLC
$183
Celgene Corporation
$172
SOBI, INC
$154
Bayer Healthcare Pharmaceuticals Inc.
$151
Lilly USA, LLC
$125
AstraZeneca Pharmaceuticals LP
$107
Takeda Pharmaceuticals U.S.A., Inc.
$106
Novartis Pharmaceuticals Corporation
$104
Janssen Biotech, Inc.
$100
GENZYME CORPORATION
$85
Mirati Therapeutics, Inc.
$84
Eisai Inc.
$81
E.R. Squibb & Sons, L.L.C.
$75
ADC Therapeutics America, Inc.
$73
Regeneron Healthcare Solutions, Inc.
$70
PharmaEssentia USA Corporation
$69
SERVIER PHARMACEUTICALS LLC
$67
ARRAY BIOPHARMA INC
$61
Adaptive Biotechnologies Corporation
$61
ABBVIE INC.
$58
Pharmacosmos Therapeutics Inc.
$58
Rigel Pharmaceuticals, Inc.
$57
Deciphera Pharmaceuticals Inc.
$54
Coherus Biosciences Inc.
$50
Exelixis Inc.
$49
Ipsen Biopharmaceuticals, Inc
$49
Astellas Pharma US Inc
$45
EMD Serono, Inc.
$42
Telix Pharmaceuticals
$34
Genentech USA, Inc.
$33
Gilead Sciences, Inc.
$33
BeiGene USA, Inc.
$32
JAZZ PHARMACEUTICALS INC.
$32
Dendreon Pharmaceuticals LLC
$30
Novocure Inc.
$30
Alexion Pharmaceuticals, Inc.
$28
Stemline Therapeutics Inc.
$27
MorphoSys, US Inc.
$25
Fennec Pharmaceuticals, Inc.
$25
Genmab U.S., Inc.
$23
Azurity Pharmaceuticals, Inc.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
Verity Pharmaceuticals Inc.
$15
Top 3 companies account for 20.4% of 2024 payments
All-time payments by company (2022-2024) ›
PFIZER INC.
$400
Merck Sharp & Dohme LLC
$361
Daiichi Sankyo Inc.
$351
Celgene Corporation
$348
Lilly USA, LLC
$261
GlaxoSmithKline, LLC.
$225
Tempus AI, Inc
$218
Takeda Pharmaceuticals U.S.A., Inc.
$217
AstraZeneca Pharmaceuticals LP
$194
SOBI, INC
$189
GENZYME CORPORATION
$179
Myriad Genetic Laboratories, Inc.
$166
Novartis Pharmaceuticals Corporation
$157
Janssen Biotech, Inc.
$152
Bayer Healthcare Pharmaceuticals Inc.
$151
Mirati Therapeutics, Inc.
$134
Pharmacosmos Therapeutics Inc.
$128
E.R. Squibb & Sons, L.L.C.
$124
Eisai Inc.
$122
ADC Therapeutics America, Inc.
$114
Coherus Biosciences Inc.
$114
Genentech USA, Inc.
$112
Seagen Inc.
$107
EMD Serono, Inc.
$103
ABBVIE INC.
$102
Astellas Pharma US Inc
$93
SERVIER PHARMACEUTICALS LLC
$91
Kite Pharma, Inc.
$80
Octapharma USA, Inc.
$79
Incyte Corporation
$76
Regeneron Healthcare Solutions, Inc.
$70
PharmaEssentia USA Corporation
$69
Jazz Pharmaceuticals Inc.
$64
ARRAY BIOPHARMA INC
$61
Adaptive Biotechnologies Corporation
$61
Alexion Pharmaceuticals, Inc.
$59
Rigel Pharmaceuticals, Inc.
$57
Deciphera Pharmaceuticals Inc.
$54
Exelixis Inc.
$49
Ipsen Biopharmaceuticals, Inc
$49
MorphoSys, US Inc.
$48
Genmab U.S., Inc.
$46
TAIHO ONCOLOGY, INC.
$42
Verity Pharmaceuticals Inc.
$37
Telix Pharmaceuticals
$34
Gilead Sciences, Inc.
$33
BeiGene USA, Inc.
$32
JAZZ PHARMACEUTICALS INC.
$32
Dendreon Pharmaceuticals LLC
$30
Novocure Inc.
$30
Stemline Therapeutics Inc.
$27
Amneal Pharmaceuticals LLC
$27
Blue Earth Diagnostics Limited
$26
Fennec Pharmaceuticals, Inc.
$25
Pharmacyclics LLC, An AbbVie Company
$25
Kyowa Kirin, Inc.
$22
Azurity Pharmaceuticals, Inc.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
G1 Therapeutics, Inc.
$20
Agios Pharmaceuticals, Inc.
$19
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 17.5% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · AVASTIN · Axumin · BAVENCIO · BESREMI · BOSULIF · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · DOPTELET · Doptelet · ELREXFIO · ENJAYMO · ERLEADA · Enhertu · Epkinly · FARXIGA · IBRANCE · IDHIFA · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · Lenvima · Lunsumio · MONJUVI · MONOFERRIC · MYCHOICE CDX · MYRISK · NINLARO · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OPDUALAG · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PRECISETUMOR · PROVENGE · PYRUKYND · Padcev · Pedmark · Phesgo · Polivy · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · Stivarga · TECVAYLI · TEPMETKO · TIVDAK · TUKYSA · Tecentriq · Tibsovo · Trelstar · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · VONVENDI · XALKORI · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Hialeah?
Compare hematology & oncology specialists in the Hialeah area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
200
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
PALMETTO GENERAL HOSPITAL
3.3 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ochoa Planchart is a hematology & oncology specialist, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Ochoa Planchart receive payments from pharmaceutical companies?
Yes. Dr. Ochoa Planchart received a total of $6,349 from 61 companies across 255 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Ochoa Planchart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →